CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 56 filers reported holding CARA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $868,000 | +10.0% | 93,427 | -1.2% | 0.00% | 0.0% |
| Q3 2016 | $789,000 | +95.8% | 94,540 | +12.9% | 0.00% | 0.0% |
| Q2 2016 | $403,000 | -8.0% | 83,757 | +19.0% | 0.00% | 0.0% |
| Q1 2016 | $438,000 | -62.5% | 70,406 | +1.5% | 0.00% | 0.0% |
| Q4 2015 | $1,169,000 | +19.3% | 69,347 | +1.1% | 0.00% | 0.0% |
| Q3 2015 | $980,000 | +39.4% | 68,571 | +18.5% | 0.00% | 0.0% |
| Q2 2015 | $703,000 | +323.5% | 57,846 | +249.5% | 0.00% | – |
| Q1 2015 | $166,000 | +3.8% | 16,549 | +3.3% | 0.00% | – |
| Q4 2014 | $160,000 | +19.4% | 16,014 | 0.0% | 0.00% | – |
| Q3 2014 | $134,000 | -50.6% | 16,014 | +0.5% | 0.00% | – |
| Q2 2014 | $271,000 | -1.5% | 15,939 | +7.7% | 0.00% | – |
| Q1 2014 | $275,000 | – | 14,798 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $47,864,000 | 31.00% |
| Chescapmanager LLC | 1,484,303 | $25,382,000 | 4.27% |
| Cypress Capital Management LLC (WY) | 179,920 | $3,077,000 | 3.07% |
| DAFNA Capital Management LLC | 371,033 | $6,345,000 | 1.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $10,715,000 | 0.98% |
| Prosight Management, LP | 86,965 | $1,487,000 | 0.64% |
| ETF MANAGERS GROUP, LLC | 901,714 | $15,419,000 | 0.55% |
| Carmignac Gestion | 2,065,153 | $35,314,000 | 0.49% |
| Ikarian Capital, LLC | 273,524 | $4,677,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $39,330,000 | 0.32% |